PROBIOTICS AND BACTERIAL IMMUNOMODULATORS FOR PREVENTION OF RESPIRATORY INFECTIONS
https://doi.org/10.15690/vsp.v13i4.1092
Abstract
Frequent respiratory infections are the risk factor of development of chronic inflammatory diseases of a respiratory tract, bronchial asthma, and owing to arising disorders in the immunity system at the level of mucous membranes they can lead to an inflammation of a mucous membrane of a digestive and urogenital tract. Traditionally the prevention of acute respiratory infections includes sanitation of the centers of infections, and also elimination of dysbiosis and immune imbalance with the application of probiotics and bacterial immunomodulators. Therewith the probiotic means are necessary not only for restoration of normal microflora on mucous membranes (first of all, in a gastrointestinal tract), but also for optimization of immunocorrective therapy, especially when oral immunomodulators are used.
Supporting agencies: “Takeda Pharmaceuticals”, Ltd.
About the Author
N. V. Khoroshilova
Institute of Advanced Training FMBA, Moscow
Russian Federation
Russian Federation
Khoroshilova Nataliya Viktorovna, allergologist and immunologist, associated professor of the Department of Clinical Immunology and Allergology
References
1. Fendrick A. M., Monto A. S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch. Interrn. Med. 2003; 163: 487–494.
2. Markova T. P. Chasto i dlitel’no boleyushchie deti: vzglyad immunologa [Long-term and Sickly Children: Immunologist’s Opinion]. Moscow, 2014. 192 p.
3. Mel’nik O. V. Tsitomegalovirusnaya i Epshtein-Barr-virusnaya infektsiya u chasto boleyushchikh detei s porazheniem dykhatel’nykh putei. Avtoref. dis. … kand. med. nauk [Cytomegalovirus and EpsteinBarr Virus Infection in Sickly Children with Lesions of the Respiratory Tract. Author’s abstract]. St. Peteresburg, 2011. 21 p.
4. Sultanova O. D. Sostoyanie mikroekologii kishechnika u chasto i dlitel’no boleyushchikh detei. Avtoref. dis. … kand. med. nauk [Condition of Microecology of Intestine in Frequently and Chronically Ill Children. Author’s abstract]. Moscow, 2005. 22 p.
5. Shishkina T. A. Sostoyanie mikrobiotsenoza zheludochnokishechnogo trakta i ego korrektsiya u chasto i dlitel’no boleyushchikh detei v usloviyakh krupnogo promyshlennogo goroda. Avtoref. dis. … kand. med. nauk [Microbiocenosis Condition of the Gastrointestinal Tract and its Correction in Frequently and Chronically Ill Children in a Large Industrial City. Author’s abstract]. Voronezh, 2005. 23 p.
6. Khoroshilova N. V. Kliniko-immunologicheskaya otsenka effektivnosti ribomunila i nizkointensivnoi lazernoi terapii u bol’nykh khronicheskim bronkhitom. Avtoref. dis. … kand. med. nauk [Clinical and Immunological Evaluation of the Effectiveness of Ribomunil and Low-level Laser Therapy in Patients with Chronic Bronchitis. Author’s abstract]. Moscow, 1994. 21 p.
7. Khoroshilova N. V. Vopr. sovr. pediatrii — Current pediatrics. 2013; 12 (5): 86–90.
8. Lehtoranta L., Pitkaranta A., Korpela R. Probiotics in respiratory virus infections. Eur. J. Clin. Microbiol. Infect. Dis. Published online: 18 march 2014.
9. Lenoir-Wijnkoop I. Public health impact of probiotics in common respiratory tract infections. Beneficial Microbes. 2014; 5 (Suppl. 1):
10. 10. Davidson L. E., Fiorino A. M., Snydman D. R., Hibberd P. L. Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double-blind placebo-controlled trial. Eur. J. Clin. Nutr. 2011; 65 (4): 501–507.
11. Akatsu H., Arakawa H., Yamamoto T., Kanematsu T., Matsukawa N., Ohara H. Lactobacilli in jelly enhances the effect of influenza vaccination. J. Am. Geriatr. Soc. 2013; 61 (10): 1828–1830.
12. Olivares M., Diaz-Ropero H. P., Sierra S., Lara-Villostada F., Fonolia J., Navas M. et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effect of influenza vaccination. Nutrition. 2007; 23 (3): 254–260.
13. Rizzardini G., Eskesen D., Calder P. C., Capetti A., Jespersen L., Clerici M. Evaluation of the immune effects of two probiotic strains Bifidobacterium animalis, BB lactis, BB-12 and Lactobacillus paracasei ssp. paracasei, L. casei 431 in an influenza vaccination model: a randomized double-blind placebo controlled study. Brit. J. Nutr. 2012; 107 (6): 876–884.
14. Bosch H. M., Mendez M., Perez M., Farran A., Fuentes M. C., Cuune J. Lactobacillus plantarum CEC P7315 and CEC P7316 stimulate.
15. Boyle R. J., Robins-Browne R. M., Tang M. L. K. Probiotic use in clinical practice: what are the risks? Am. J. Clin. Nutr. 2006; 83: 1256–1264.
16. Kalima P., Masterton R. G., Roddie P. H., Thomas A. T. Lactobacil lus rhamnosus infection in a child following bone marrow transplantat. J. Infect. 1996; 32: 165–167.
17. Land M. H., Rouster-Stevens K., Woods C. R., Cannon M. L., Cnota J., Shetty A. K. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005; 115: 178–181.
18. Smith P. D., MacDonald T., Blumberg R. S. Principles of mucosal immunology. London and New York: Garland Science. 2013. 512 p.
19. Liao J. Y., Zhang T. Influence of OM-85BV on hBD-1 and immunoglobulin in children with asthma and recurrent respiratory tract infection. Zhongguo Dang Dai Er Ke Za Zhi. 2014; 16 (5): 508–512.
20. Schaad U. B. OM-85BV an immunostimulant in pediatric recurrent respiratory tract infection: a systemic review. World J. Pediatr. 2010; 6 (1): 5–12.
21. Steurer-Stay C., Ladler L., Straub D. A., Steurer J., Bachmann L. M. Oral purified bacterial extracts in acute respiratory tract infections in childhood. Eur. J. Pediatr. 2007; 166 (4): 365–376.
22. Sprenkle M. D., Newoehner D. E., MacDonald R., Rutks I., Wilt T. J. Clinical efficacy of OM-85BV in COPD and chronic bronchitis: a systematic review. COPD. 2005; 2 (1): 167–175.
23. Esposito S., Marchisio P., Prada E., Daleno C., Porretti L., Carsett R. et al. Impact of mixed bacterial lysate (OM-85BV) on the immunogenicity, safety and tolerability of inactivated influenza vaccine in children with recurrent respiratory tract infection. Vaccine. 2014; 32 (22): 2546–2552.
Review
For citations:
Khoroshilova N.V. PROBIOTICS AND BACTERIAL IMMUNOMODULATORS FOR PREVENTION OF RESPIRATORY INFECTIONS. Current Pediatrics. 2014;13(4):93-95. (In Russ.) https://doi.org/10.15690/vsp.v13i4.1092
Views:
1630
Email this article 
